A human liver cell-based system modeling a clinical prognostic liver signature for therapeutic discovery
Drug and target discovery for advanced liver disease are hampered by a lack of suitable models for clinical translation. Here the authors present a human liver cell-based system modeling a clinical prognostic signature allowing to propose nizatidine for treatment of advanced liver fibrosis and hepat...
Saved in:
Similar Items
-
A genome-wide gain-of-function screen identifies CDKN2C as a HBV host factor
by: Carla Eller, et al.
Published: (2020) -
Liver biopsy in the quantitative assessment of liver fibrosis in nonalcoholic fatty liver disease
by: Gwyneth Shook Ting Soon, et al.
Published: (2021) -
Liver
Published: (1981) -
Augmenter of liver regeneration (alr) promotes liver outgrowth during zebrafish hepatogenesis.
by: Yan Li, et al.
Published: (2012) -
Genome-wide association study of serum liver enzymes implicates diverse metabolic and liver pathology
by: Vincent L. Chen, et al.
Published: (2021)